Volume 16, Number 1—January 2010
Research
Recombinant Canine Coronaviruses in Dogs, Europe
Nicola Decaro
, Viviana Mari, Gabriella Elia, Diane D. Addie, Michele Camero, Maria Stella Lucente, Vito Martella, and Canio Buonavoglia
, Viviana Mari, Gabriella Elia, Diane D. Addie, Michele Camero, Maria Stella Lucente, Vito Martella, and Canio Buonavoglia
Table 3
Percent nucleotide identity of representative TGEV-like CCoVs to group-1a CoV reference strains in the 5′ and 3′ ends of the spike gene from dogs from Europe, 2001–2008*
| CoV strain | GenBank accession no. | % Identity |
|
|---|---|---|---|
| 5′ end† | 3′ end‡ | ||
| CCoV-IIb-341/05 | EU856361 | 88.1–99.3 | 94.7–99.4 |
| CCoV-IIb-174/06 | EU856362 | 86.8–99.0 | 93.3–97.0 |
| CCoV-IIb-430/07 | EU924790 | 85.9–97.3 | 92.7–97.0 |
| CCoV-IIb-119/08 | EU924791 | 89.1–99.0 | 93.7–99.8 |
| CCoV-IIb-UCD1 | AF116248 | 76.6–85.7 | NA |
| TGEV-Purdue | NC_002306 | 76.6–84.4 | 91.4–93.1 |
| TGEV-TS | DQ201447 | 76.2–84.4 | 90.8–92.5 |
| TGEV-96-1933 | AF104420 | 74.0–81.8 | 87.1–88.8 |
| PRCoV-RM4 | Z24675 | NA | 90.2–91.6 |
| PRCoV-86-137004 | X60089 | NA | 90.2–91.6 |
| CCoV-IIa-Insavc-1 | D13096 | 35.4–38.3 | 92.1–95.3 |
| CCoV-IIa-CB/05 | DQ112226 | 35.1–37.7 | 93.7–99.0 |
| CCoV-IIa-BGF10 | AY342160 | 34.2–37.5 | 90.8–94.3 |
| FCoV-II-79-1146 | NC_007025 | 34.0–36.6 | 90.2–91.6 |
| FCoV-II-79-1683 | X80799 | 34.6–37.5 | 90.4–91.9 |
| CCoV-I-Elmo/02 | AY307020 | 37.6–40.4 | 61.8–62.8 |
| CCoV-I-23/03 | AY307021 | 31.8–34.8 | 60.3–61.2 |
| FCoV-I-KU-2 | D32044 | 37.4–40.8 | 59.1–60.3 |
| FCoV-I-Black | EU186072 | 36.2–39.3 | 58.9–61.0 |
| FCoV-I-UCD1 | AB088222 | 38.3–42.7 | 57.9–58.9 |
*TGEV, porcine transmissible gastroenteritis virus; CCoV, canine coronavirus; NA, sequence not available.
†Nucleotides 1–305 of the spike gene of reference strain CCoV-IIb-341/05.
‡Nucleotides 3574–4085 of the spike gene of reference strain CCoV-IIb-341/05.
Page created: March 31, 2011
Page updated: March 31, 2011
Page reviewed: March 31, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.